Director, Respiratory Biologics - Global Real-World Evidence & Health Outcomes Research

Position Summary

For drugs to be successful, there must be robust health outcomes data to support launch optimization, reimbursement and maintain market position. Specifically, evidence must be maintained throughout the product lifecycle as standard of care changes, new competitors are introduced, and patents expire on existing competitors. The landscape is evolving quickly as trials demonstrating efficacy in an area of unmet need may receive expedited review, or orphan product status designation which affects both GSK and competitors launch timelines and approval requirements. More and more of our customers are developing sophisticated internal health outcomes capabilities and access to real world data that can be used to better understand unmet needs and real-world effectiveness of our medicines. We need to better understand how our customers define value and to effectively collaborate with them to ensure we are generating value evidence data that includes real world evidence and cost effectiveness analysis that is impactful for payers, health systems, providers, and patients.

The role of Director is critical to achieving this ambition by supporting asset teams to ensure that each medicine GSK brings to market is supported by scientifically credible, high quality, evidence that drives competitiveness and strong evidence-based product positioning, value propositions and value-based pricing. The role is critical to support the alignment of evidence with evidentiary requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use and commercial success.

The role will report directly into the Senior Director, Global Real-World Evidence & Health Outcomes Research Lead for the Respiratory Biologics portfolio and will have expertise in real-world evidence and other non-interventional study methods. The role is expected to have a cross-indication remit, supporting launch of a fast-moving high priority program. The Director will be accountable for engaging closely with global and country level data generation partners, and will actively support data generation planning, study design, execution, translation and dissemination across indications for the asset.

This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:

• Plan, design and execute RWE and qualitative research studies for a high priority asset and manage timelines, deliverables, and budget. Assure quality of deliverables, including review and sign off project specifications, protocols, data analysis plans, final study reports, abstracts, posters and manuscripts, adherence to SOPs.

• Ensure alignment of local data generation efforts with data generation plan and enable effective global-local information sharing on data generation studies

• Build strong working relationships with stakeholder groups across countries, medical, market access, R&D and commercial to ensure strategic alignment and optimal cross-functional collaboration and communication

Why You?

Work arrangement
This role is hybrid, blending remote and in-office work to support collaboration and flexibility. Candidates must be located in the United States and able to travel as needed.

Basic Qualification
We are seeking professionals with the following required skills and qualifications to help us achieve our goals

• Masters in health outcomes, patient reported outcomes, health economics, epidemiology, pharmacy, health or life sciences.

• 10 + years’ experience working in pharmaceutical industry, preferably in a multi-national company.

• Experience with evidence generation planning and workshop development

• Experience developing detailed project and program plans.

• Experience delivering studies and related communications to the matrix in a fast-paced environment.

• Experience with a variety of study designs, i.e., RWE studies including prospective, cross-sectional and retrospective cohort studies. Must have experience with patient reported outcomes research.

• Knowledge of the diversity and complexity of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and in local markets.

• Applied experience in utilizing evidence for the development of HTA submissions, reimbursement and/or medical engagement.

• Experience communicating technical and complex concepts and results effectively to various audiences to impact decision-making, including impactful slide presentations to senior leaders.

Preferred Qualification
If you have the following characteristics, it would be a plus

• Advanced scientific degree, e.g. PhD, PharmD or equivalent in health outcomes or similar.

• Experience leading projects, leading client communications and developing project plans from a health economics and outcomes research consulting perspective.

• Health economics and outcomes research experience in asthma.

• Methods expertise to effectively deliver robust payer evidence and credibility to engage meaningfully with external experts & leaders in the field.

#LI-GSK

The US annual base salary for new hires in this position ranges from $185,250 to $308,750. The US salary ranges take into account a number of factors including work location within the US market, the candidate’s skills, experience, education level and the market rate for the role. In addition, this position offers an annual bonus and eligibility to participate in our share based long term incentive program which is dependent on the level of the role. Available benefits include health care and other insurance benefits (for employee and family), retirement benefits, paid holidays, vacation, and paid caregiver/parental and medical leave. If salary ranges are not displayed in the job posting for a specific country, the relevant compensation will be discussed during the recruitment process.

Please visit to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK.